Literature DB >> 32970156

Assessment of Disparities in COVID-19 Testing and Infection Across Language Groups in Seattle, Washington.

H Nina Kim1,2,3, Kristine F Lan1,2, Esi Nkyekyer1,3, Santiago Neme1,2, Martine Pierre-Louis3, Lisa Chew1,3, Herbert C Duber3,4,5.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 32970156      PMCID: PMC7516622          DOI: 10.1001/jamanetworkopen.2020.21213

Source DB:  PubMed          Journal:  JAMA Netw Open        ISSN: 2574-3805


× No keyword cloud information.

Introduction

Clinicians from New York, New York, have raised the alarm that the coronavirus disease 2019 (COVID-19) pandemic has taken a disproportionate toll on their local immigrant communities.[1] Immigrants may be more susceptible to exposure because more of them work in essential industries or reside in larger multigenerational households.[2] Limited English language proficiency (LEP) or low health literacy can present challenges to effective communication about disease transmission.[3] Worries about stigma, deportation, or livelihood may supersede those of a health threat, however serious.[4] It remains unclear whether these disparities have resulted in lower comparative access to testing for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a patient-initiated option in all but congregant settings, or in higher rates of infection among immigrants. To clarify this issue, we evaluated the proportion of patients who completed testing and the proportion of positive cases using language as a surrogate for immigrant status.

Methods

This analysis was approved by the University of Washington human subjects division. A waiver of consent was granted because the study is a retrospective data analysis of deidentified data and not considered human subjects research. This cross-sectional study follows the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) reporting guideline. The University of Washington Medicine system comprises 3 hospitals and more than 300 clinics across the Puget Sound region. Nasopharyngeal samples were tested for SARS-CoV-2 using a real-time reverse transcriptase–polymerase chain reaction test developed by the University of Washington Virology laboratory.[5] After identifying all living patients who had at least 1 encounter (including telephone or telemedicine) in our system from January 1, 2019, to February 28, 2020, we assessed SARS-CoV-2 testing from February 29 when testing first started to May 31, 2020, as (1) the proportion of those tested and (2) the proportion of those who tested positive over those tested, and calculated 95% CIs using a standard error of the proportion formula. Results were stratified by language, designated by the patient and captured on registration as their preferred spoken language. Data analysis was performed using R statistical software version 3.6.3 (R Project for Statistical Computing) on August 4, 2020.

Results

Overall, 30 925 of 562 242 patients (5.5%) underwent SARS-CoV-2 testing. The mean (SD) age of the patients was 49 (18.3) years, and 16 152 (52.2%) were women. Of these, 1869 (6.0%) were non-English speakers. Non-English speakers were overall less likely to have completed testing compared with English-speakers (4.7% [95% CI, 4.5%-4.9%] vs 5.6% [95% CI, 5.6%-5.7%]) but the proportion tested varied across language groups (Figure 1). Notably, the proportion of positive cases was 4.6-fold higher among non-English speakers overall (18.6%; 95% CI, 16.8%-20.4%) compared with English speakers (4.0%; 95% CI, 3.8%-4.2%) (Figure 2). This excess risk was observed across multiple languages and in the 3 largest non–English-speaking groups—Spanish, Vietnamese, and Amharic—reflecting the larger immigrant communities in King County, WA.
Figure 1.

Proportion of Patients Tested for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) by Language

Estimates and 95% CIs are shown for English, pooled non-English languages, and the 12 most populous non-English languages. Language was missing for 10 844 (1.9%) of 562 242 individuals assessed.

Figure 2.

Proportion of Patients Testing Positive for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) by Language

Estimates and 95% CIs are shown for English, pooled non-English languages, and the 12 most populous non-English languages. Language was missing for 291 (1%) of 30 925 individuals tested.

Proportion of Patients Tested for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) by Language

Estimates and 95% CIs are shown for English, pooled non-English languages, and the 12 most populous non-English languages. Language was missing for 10 844 (1.9%) of 562 242 individuals assessed.

Proportion of Patients Testing Positive for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) by Language

Estimates and 95% CIs are shown for English, pooled non-English languages, and the 12 most populous non-English languages. Language was missing for 291 (1%) of 30 925 individuals tested.

Discussion

A deeper understanding of disparities in health care requires a closer look at structural inequities and other social determinants of health. In the US, LEP has been shown to be associated with quality of care, health care–seeking behavior, and health outcomes.[6] Our study found that despite the availability of interpreter services across clinical locations, non–English-speaking patients in our health system were tested less frequently for COVID-19 and had significantly higher burden of infection. Interestingly, we found substantial heterogeneity in both test and test positivity rates by language. Higher testing rates were noted among those language groups living in neighborhoods where community-based testing strategies were implemented. Our outreach efforts, which included mobile clinics and drive-up testing, was implemented in partnership with local health coalitions representing communities of color to overcome testing barriers and should be considered where limited access and disproportionate rates of infection are a concern. Our descriptive analysis of the distribution of COVID-19 testing and infection among LEP communities within a single health system should be interpreted within the context of certain limitations. Testing rates shown here may not reflect the true testing rate of the LEP community in our region because we examined only University of Washington Medicine testing and defined our patient population by requiring documented contact in the past year, which might have introduced selection bias. Second, language may not accurately represent how immigrant community members identify. Third, we did not adjust for potential confounding or mediating factors to understand the true association between LEP and COVID-19 testing and infection. Until we routinely examine quality of care outcomes by granular demographic measures, such as language or country of origin, disparities in care for immigrants can continue to remain hidden.
  29 in total

1.  Community-Engaged Bidirectional Crisis and Emergency Risk Communication With Immigrant and Refugee Populations During the COVID-19 Pandemic.

Authors:  Mark L Wieland; Gladys B Asiedu; Jane W Njeru; Jennifer A Weis; Kiley Lantz; Adeline Abbenyi; Luz Molina; Yahye Ahmed; Ahmed Osman; Miriam Goodson; Gloria Torres-Herbeck; Omar Nur; Graciela Porraz Capetillo; Ahmed A Mohamed; Irene G Sia
Journal:  Public Health Rep       Date:  2022-01-13       Impact factor: 2.792

2.  COVID-19 Testing Among US Children, Parental Preferences for Testing Venues, and Acceptability of School-Based Testing.

Authors:  Chloe A Teasdale; Luisa N Borrell; Yanhan Shen; Spencer Kimball; Michael L Rinke; Madhura S Rane; Sarah Kulkarni; Sasha A Fleary; Denis Nash
Journal:  Public Health Rep       Date:  2022-01-13       Impact factor: 2.792

3.  Extracting Patient-level Social Determinants of Health into the OMOP Common Data Model.

Authors:  Jimmy Phuong; Elizabeth Zampino; Nicholas Dobbins; Juan Espinoza; Daniella Meeker; Heidi Spratt; Charisse Madlock-Brown; Nicole G Weiskopf; Adam Wilcox
Journal:  AMIA Annu Symp Proc       Date:  2022-02-21

4.  What must be done to tackle vaccine hesitancy and barriers to COVID-19 vaccination in migrants?

Authors:  Alison F Crawshaw; Anna Deal; Kieran Rustage; Alice S Forster; Ines Campos-Matos; Tushna Vandrevala; Andrea Würz; Anastasia Pharris; Jonathan E Suk; John Kinsman; Charlotte Deogan; Anna Miller; Silvia Declich; Chris Greenaway; Teymur Noori; Sally Hargreaves
Journal:  J Travel Med       Date:  2021-06-01       Impact factor: 8.490

5.  Clinical outcomes and risk factors for COVID-19 among migrant populations in high-income countries: A systematic review.

Authors:  Sally E Hayward; Anna Deal; Cherie Cheng; Alison Crawshaw; Miriam Orcutt; Tushna F Vandrevala; Marie Norredam; Manuel Carballo; Yusuf Ciftci; Ana Requena-Méndez; Christina Greenaway; Jessica Carter; Felicity Knights; Anushka Mehrotra; Farah Seedat; Kayvan Bozorgmehr; Apostolos Veizis; Ines Campos-Matos; Fatima Wurie; Martin McKee; Bernadette Kumar; Sally Hargreaves
Journal:  J Migr Health       Date:  2021-04-22

6.  Differences in access to virtual and in-person primary care by race/ethnicity and community social vulnerability among adults diagnosed with COVID-19 in a large, multi-state health system.

Authors:  Diana J Govier; Hannah Cohen-Cline; Katherine Marsi; Sarah E Roth
Journal:  BMC Health Serv Res       Date:  2022-04-15       Impact factor: 2.908

7.  Use of Zip Code Based Aggregate Indicators to Assess Race Disparities in COVID-19.

Authors:  Kevin D Long; Steven M Albert
Journal:  Ethn Dis       Date:  2021-07-15       Impact factor: 1.847

8.  Potential for bias in assessing risk and protective factors for COVID-19: Commentary on Conlon et al.'s "Impact of the influenza vaccination on COVID-19 infection rates and severity".

Authors:  Pablo K Valente
Journal:  Am J Infect Control       Date:  2021-08       Impact factor: 2.918

9.  Healthcare workers' perspectives on coronavirus testing availability: a cross sectional survey.

Authors:  Elena Byhoff; Jessica K Paulus; Rubeen Guardado; Julia Zubiago; Alysse G Wurcel
Journal:  BMC Health Serv Res       Date:  2021-07-21       Impact factor: 2.655

10.  Policy Implementation Science to Advance Population Health: The Potential for Learning Health Policy Systems.

Authors:  April Oh; Ali Abazeed; David A Chambers
Journal:  Front Public Health       Date:  2021-06-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.